Unveiling the Rarity: Chronic Myeloid Leukaemia in Children and Adults: A Comparative Analysis

Somnath Saha Roy, Anannya Indra Kashyap, Navil F. Islam, Jinku Ozah, Sofiur Rahman, Ajit K. Pegu

Abstract: Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a blood cancer in which an excessive amount of the white blood cell granulocytes are produced by the bone marrow. CML risk rises with age, and childhood cases are incredibly rare. It is a relatively rare condition that only makes up 3?5% of all pediatric malignancies in children.Because acute leukemias are often more prevalent in children, the term "childhood leukemias" is frequently used to characterize them. Chronic leukemias, such as Chronic Myeloid Leukemia (CML), affect almost exclusively adults. Due to the normal age of diagnosis being around 60 years old in western countries, CML in children is considered to be a very rare condition. The higher leukocyte count that distinguishes children with CML from adults with CML at presentation, together with other symptoms such weariness, fever, awareness of a mass due to splenomegaly, and bleeding signs, is the main difference between the two groups of patients.

Keywords: leukemia, children, chronic myeloid leukemia

How to Cite?: Somnath Saha Roy, Anannya Indra Kashyap, Navil F. Islam, Jinku Ozah, Sofiur Rahman, Ajit K. Pegu, "Unveiling the Rarity: Chronic Myeloid Leukaemia in Children and Adults: A Comparative Analysis", Volume 12 Issue 8, August 2023, International Journal of Science and Research (IJSR), Pages: 1322-1326, https://www.ijsr.net/getabstract.php?paperid=SR23813004155, DOI: https://dx.doi.org/10.21275/SR23813004155